Close Menu

NEW YORK – Sight Diagnostics announced on Wednesday a distribution deal with Phoenix Capital to provide Sight OLO blood analyzers to medical centers in the Middle East.

OLO is a decentralized blood count diagnostic technology that captures more than 1,000 images from two drops of blood from a finger prick or venous sample. The instrument is about the size of a toaster oven and does not require reagents or manual quality control checks.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.